IMPACT OF PSORIATIC ARTHRITIS MANIFESTATIONS ON PERCEPTION OF PAIN IMPROVEMENT: POOLED ANALYSIS OF TWO PHASE 3, RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED STUDIES WITH GUSELKUMAB

被引：0
|
作者：
Nash, P. [1 ,2 ]
Mcinnes, I. [3 ]
Ritchlin, C. T. [4 ]
Tam, L. S. [5 ]
Soriano, E. [6 ]
Starr, M. [7 ]
Rampakakis, E. [8 ,9 ]
Lavie, F. [10 ]
Shawi, M. [11 ]
Baraliakos, X. [12 ,13 ]
Mease, P. J. [14 ,15 ]
机构：
[1] Griffith Univ, Maroochydore, Australia
[2] Univ Queensland, Rheumatol Res Unit, Maroochydore, Australia
[3] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Scotland
[4] Univ Rochester, Dept Med Allergy Immunol & Rheumatol, Med Ctr, Rochester, NY USA
[5] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China
[6] Hosp Italiano Buenos Aires, Rheumatol, Buenos Aires, Argentina
[7] McGill Univ, Div Rheumatol, Hlth Ctr, Montreal, PQ, Canada
[8] McGill Univ, Dept Pediat, Montreal, PQ, Canada
[9] JSS Med Res Inc, Sci Affairs, Montreal, PQ, Canada
[10] Janssen Cilag Global Med Affairs, Immunol Global Med Affairs, Issy Les Moulineaux, France
[11] Janssen Pharmaceut Co Johnson & Johnson, Immunol Global Med Affairs, Horsham, PA USA
[12] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany
[13] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA
[14] St Joseph Hlth, Seattle, WA USA
[15] Univ Washington, Rheumatol Res, Seattle, WA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
bDMARD; Pain; Psoriatic arthritis; BIOLOGIC-NAIVE; DOUBLE-BLIND;
D O I：
10.1136/annrheumdis-2023-eular.555
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1095
引用
收藏
页码：1771 / 1772
页数：2
相关论文
共 50 条
  • [41] Neutrophil Levels Associate with Early Improvement in Spinal Pain and Week 24 Multi-Domain Disease Control During Guselkumab Treatment in Active Psoriatic Arthritis: Post Hoc Pooled Analyses of Two Phase 3 Randomized Controlled Trials
    Macleod, Thomas
    Baraliakos, Xenofon
    Rampakakis, Emmanouil
    Chen, Warner
    Van Den Heuvel, Antonius Pieter J.
    Seridi, Loqmane
    Shawi, May
    Lavie, Frederic
    Merola, Joseph F.
    Rahman, Proton
    McGonagle, Dennis
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4409 - 4411
  • [42] Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo-controlled studies of varenicline
    Tonstad, Serena
    Lawrence, David
    JOURNAL OF DIABETES INVESTIGATION, 2017, 8 (01) : 93 - 100
  • [43] Guselkumab (TREMFYA®) Improves Anemia in Patients with Active Psoriatic Arthritis: Results from Two Phase 3 Randomized Controlled Clinical Trials
    Kavanaugh, Arthur
    Liu, Yan
    Rahman, Proton
    Mease, Philip
    Gossec, Laure
    Xu, Xie
    Hsia, Elizabeth
    Shawi, May
    Han, Chenglong
    Neuhold, Marlies
    Deodhar, Atul
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2763 - 2766
  • [44] A Pooled Analysis of 3 Randomized, Placebo-Controlled, Phase 3 Studies Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Armodafinil in Bipolar I Depression
    Frye, Mark
    Amchin, Jess
    Yang, Ronghua
    Ketter, Terrence
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S474 - S475
  • [45] Results from a Pooled Analysis of Two European, Randomized, Placebo-Controlled, Phase 3 Studies of ATX-101 for the Pharmacologic Reduction of Excess Submental Fat
    James McDiarmid
    Jesus Benito Ruiz
    Daniel Lee
    Susanne Lippert
    Claudia Hartisch
    Blanka Havlickova
    Aesthetic Plastic Surgery, 2014, 38 : 849 - 860
  • [46] Results from a Pooled Analysis of Two European, Randomized, Placebo-Controlled, Phase 3 Studies of ATX-101 for the Pharmacologic Reduction of Excess Submental Fat
    McDiarmid, James
    Benito Ruiz, Jesus
    Lee, Daniel
    Lippert, Susanne
    Hartisch, Claudia
    Havlickova, Blanka
    AESTHETIC PLASTIC SURGERY, 2014, 38 (05) : 849 - 860
  • [47] Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study
    Mease, Philip J.
    Gladman, Dafna D.
    Poddubnyy, Denis
    Chakravarty, Soumya D.
    Shawi, May
    Kollmeier, Alexa P.
    Xu, Xie L.
    Xu, Stephen
    Deodhar, Atul
    Baraliakos, Xenofon
    RHEUMATOLOGY AND THERAPY, 2023, 10 (06) : 1637 - 1653
  • [48] The Effect of Guselkumab on Work Productivity in Biologic-Naive Patients with Active Psoriatic Arthritis Through Week 52 of the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Trial
    Curtis, Jeffrey R.
    McInnes, Iain B.
    Rahman, Proton
    Gladman, Dafna D.
    Peterson, Steven
    Agarwal, Prasheen
    Yang, Feifei
    Kollmeier, Alexa P.
    Hsia, Elizabeth C.
    Shiff, Natalie J.
    Zhou, Bei
    Han, Chenglong
    Shawi, May
    Tillett, William
    Mease, Philip J.
    ADVANCES IN THERAPY, 2022, 39 (10) : 4613 - 4631
  • [49] Impact of Fremanezumab on Disability Severity According to the AHS Consensus: Pooled Results of 3 Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
    Nagy, A. J.
    Cohen, J. M.
    Ning, X.
    Ramirez-Campos, V
    Yang, R.
    Ashina, M.
    HEADACHE, 2020, 60 : 18 - 18
  • [50] Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study
    Philip J. Mease
    Dafna D. Gladman
    Denis Poddubnyy
    Soumya D. Chakravarty
    May Shawi
    Alexa P. Kollmeier
    Xie L. Xu
    Stephen Xu
    Atul Deodhar
    Xenofon Baraliakos
    Rheumatology and Therapy, 2023, 10 : 1637 - 1653
12345